STOCK TITAN

Pulsenmore Ltd Financials

PLSM
Source SEC Filings (10-K/10-Q) Updated Mar 30, 2026 Currency USD FYE March

This page shows Pulsenmore Ltd (PLSM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 50 / 100
Financial Profile 50/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Leverage
100

Pulsenmore Ltd carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
100

With a current ratio of 7.88, Pulsenmore Ltd holds $7.88 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow
0

While Pulsenmore Ltd generated -$10.3M in operating cash flow, capex of $42K consumed most of it, leaving -$10.3M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns
0

Pulsenmore Ltd generates a -19.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.

Earnings Quality Low Quality
2.07x

For every $1 of reported earnings, Pulsenmore Ltd generates $2.07 in operating cash flow (-$10.3M OCF vs -$5.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$12.5M

Pulsenmore Ltd generated $12.5M in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
-$5.0M

Pulsenmore Ltd reported -$5.0M in net income in fiscal year 2025.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
-$10.3M

Pulsenmore Ltd generated -$10.3M in free cash flow in fiscal year 2025, representing cash available after capex.

Cash & Debt
$6.8M

Pulsenmore Ltd held $6.8M in cash against $170K in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
7M

Pulsenmore Ltd had 7M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
-39.6%

Pulsenmore Ltd's net profit margin was -39.6% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity
-19.1%

Pulsenmore Ltd's ROE was -19.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$42K

Pulsenmore Ltd invested $42K in capex in fiscal year 2025, funding long-term assets and infrastructure.

PLSM Income Statement

PLSM Balance Sheet

PLSM Cash Flow Statement

PLSM Financial Ratios

Frequently Asked Questions

Pulsenmore Ltd (PLSM) reported $12.5M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Pulsenmore Ltd (PLSM) reported a net income of -$5.0M in fiscal year 2025, with a net profit margin of -39.6%.

As of fiscal year 2025, Pulsenmore Ltd (PLSM) had $6.8M in cash and equivalents against $170K in long-term debt.

Pulsenmore Ltd (PLSM) had a net profit margin of -39.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Pulsenmore Ltd (PLSM) has a return on equity of -19.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Pulsenmore Ltd (PLSM) generated -$10.3M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Pulsenmore Ltd (PLSM) generated -$10.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Pulsenmore Ltd (PLSM) had $31.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Pulsenmore Ltd (PLSM) invested $42K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Pulsenmore Ltd (PLSM) had 7M shares outstanding as of fiscal year 2025.

Pulsenmore Ltd (PLSM) had a current ratio of 7.88 as of fiscal year 2025, which is generally considered healthy.

Pulsenmore Ltd (PLSM) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Pulsenmore Ltd (PLSM) had a return on assets of -15.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Pulsenmore Ltd (PLSM) had $6.8M in cash against an annual operating cash burn of $10.3M. This gives an estimated cash runway of approximately 8 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Pulsenmore Ltd (PLSM) has an earnings quality ratio of 2.07x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Pulsenmore Ltd (PLSM) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top